innovative drug articles & resources on Made-in-China.com

China Will Develop Strategic Emerging Industries

Jun 12, 2015

China will come out with a five-year plan (2016-20) for the development of its strategic emerging industries and to further boost its innovation efforts, the nation's top economic planner said on Friday. The National Development and ...

Tags: Emerging Industries, Economy

Sagent Pharmaceuticals Launches Octreotide Acetate Injection,a Somatostatin Analog

Dec 26, 2013

Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Octreotide Acetate Injection, a Somatostatin Analog, in five vial presentations. According to IMS, for the 12 months ending October 2013, the US market for Octreotide ...

Tags: Health, Medicine

US-Based Sagent Pharmaceuticals Has Introduced Propofol Injectable Emulsion USP 1%

Nov 20, 2013

US-based Sagent Pharmaceuticals has introduced propofol injectable emulsion USP 1%, in two single-dose, single-patient vial presentations of 20mL and 100mL. The company said that a 50mL single-dose, single-patient vial presentation will ...

Tags: Sagent, Medicine

Alzheon Announced The Launch of The Company,The Securing of Initial Private Financing

Oct 28, 2013

Alzheon announced the launch of the company, the securing of initial private financing, and the signing of an exclusive license agreement to a novel clinical drug candidate for Alzheimer’s disease, a family of analogs, and a drug ...

Tags: Alzheon, Alzheimer's Disease

Accelrys Has Completed The Roll-out of Its Next-generation Cheminformatics Suite

Sep 25, 2013

Accelrys, a US-based provider of lifecycle management solutions, has completed the roll-out of its next-generation cheminformatics suite, with the launch of Accelrys Insight and Accelrys Insight for Excel. Both the solutions will help in ...

Tags: lifecycle management, Medicine

Inventiva and Novalix Enter Into a Strategic Alliance to Discover The Clinical Candidates

Apr 15, 2013

Inventiva and Novalix have entered into a strategic alliance to discover the clinical candidates, targeting nuclear receptors. As part of the agreement, Inventiva and NovAliX offer pharmaceutical and biotech companies a set of fully ...

Tags: NovAliX, clinical candidates

PolyPid Has Signed a Strategic Partnership Agreement with MIS Implants Technologies

Mar 8, 2013

Israel-based innovative drug carriers developer PolyPid has signed a strategic partnership agreement with MIS Implants Technologies, a US- based dental implants manufacturer, to provide a new drug delivery product for dental applications. ...

Tags: MIS, drug delivery product, innovative drug

innovative drug